PMD5 VALUATION OF NEW DRUG APPLICATIONS OF PHARMACEUTICAL COMPANIES USING COMPOUND OPTION MODELS
Danny Cassimon+3 more
openalex +1 more source
The Sequential Compound Option Pricing with Random Interest Rate and Application to Project Valuation [PDF]
Meng-Yu Lee, Fang Bo Yeh, An‐Pin Chen
openalex +1 more source
Estimating a preference-based index for patients with myasthenia gravis from the MGQoL-6D measure. [PDF]
Xu RH, Norman R, Liu J, Dong D.
europepmc +1 more source
Beyond ordinal scales: making animal welfare count in policy analysis. [PDF]
Fischer B.
europepmc +1 more source
Does Recognition Versus Disclosure Really Matter? Evidence from the Market Valuation of Recognition of Employee Stock Option Expenses* [PDF]
Flora Niu, Bixia Xu
openalex +1 more source
Stochastic heuristics for decisions under risk and uncertainty. [PDF]
Spiliopoulos L, Hertwig R.
europepmc +1 more source
The existing closed-form models for the valuation of call options in solid mineral land use/development; (including the Samuelson-McKean model) often feature deterministic inputs and outputs that inadequately account for the dynamics of risk and ...
J. O. Ataguba, J. C. Onyejiaka
doaj
Effectiveness analysis and value incommensurability. [PDF]
Herlitz A.
europepmc +1 more source
Option Valuation with Long-Run and Short-Run Volatility Components [PDF]
Peter Christoffersen+3 more
openalex +1 more source
The human reward system encodes the subjective value of ideas during creative thinking. [PDF]
Moreno-Rodriguez S+3 more
europepmc +1 more source